Concluding remarks

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 686-690

  Marmont, Alberto M ^a   Saccardi, Riccardo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYELODYSPLASTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METHODOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 65449139073     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802200240     Document Type: Article

References (64)

1. Marmont, AM (2000) New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation. Annu Rev Med, 51, pp. 115-134.
2. Smith-Berdan, S., Gille, D., Weissman, IL and Christensen, JL (2007) Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood, 110:4, pp. 1370-1378.
3. Marmont, AM (2004) Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol, 17:2, pp. 223-232.
4. Ikehara, S., Kawamura, M. Takao, F. et al. (1990) Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA, 87:21, pp. 8341-8344.
5. Hinterberger, W., Hinterberger-Fischer, M. and Marmont, A. (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant, 30:11, pp. 753-759.
6. Marmont, AM (2004) Is there any evidence of a graft-versus-autoimmunity effect in allogeneic transplantation?. Blood Marrow Transplant, p. 11.
7. Kojima, R., Kami, M. Kim, SW et al. (2003) Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 32:4, pp. 439-442.
8. Van Wijmeersch, B., Sprangers, B. Rutgeerts, O. et al. (2007) Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: Evidence for a graft-versus-autoimmunity effect. Biol Blood Marrow Transplant, 13:6, pp. 627-637.
9. Griffith, LM, Pavletic, SZ Tyndall, A. et al. (2005) Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: Position statement from a national institute of allergy and infectious diseases and national cancer institute-sponsored international workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant, 11:11, pp. 862-870.
10. Griffith, LM, Pavletic, SZ Tyndall, A. et al. (2006) Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases-a workshop accompanying: Cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy. Biol Blood Marrow Transplant, 12:6, pp. 688-690.
11. Urban, C., Lackner, H. Sovinz, P. et al. (2006) Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol, 76:6, pp. 526-530.
12. Lowenthal, RM, Francis, H. and Gill, DS (2006) Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant. J Rheumatol, 33:4, pp. 812-813.
13. Marmont, AM, Gualandi, F. Piaggio, G. et al. (2006) Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement. Bone Marrow Transplant, 37:11, pp. 1061-1063.
14. McKendry, RJ, Huebsch, L. and Leclair, B. (1996) Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup. Arthritis Rheum, 39:7, pp. 1246-1253.
15. Tapprich, C., Fenk, R. Schneider, P. et al. (2003) Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma. Bone Marrow Transplant, 32:6, pp. 629-631.
16. Seung, E., Iwakoshi, N. Woda, BA et al. (2000) Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood, 95:6, pp. 2175-2182.
17. Nikolic, B., Takeuchi, Y. Leykin, I. et al. (2004) Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes, 53:2, pp. 376-383.
18. Verda, L., Kim, DA Ikehara, S. et al. (2008) Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice. Stem Cells, 26:2, pp. 381-386.
19. Chakrabarti, S., Handa, SK Bryon, RJ et al. (2001) Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?. Transplantation, 72:2, pp. 340-342.
20. Burt, RK, Oyama, Y. Verda, L. et al. (2004) Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum, 50:8, pp. 2466-2470.
21. Khorshid, O., Hosing, C. Bibawi, S. et al. (2004) Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol, 31:12, pp. 2513-2516.
22. Marmont, AM, Gualandi, F., Van Lint, MT and Bacigalupo, A. (2003) Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant, 31:5, pp. 399-402.
23. Pavletic, SZ (2004) Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease. Arthritis Rheum, 50:8, pp. 2387-2390.
24. Loh, Y., Oyama, Y. Statkute, L. et al. (2007) Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: Graft-versus-autoimmunity without graft-versus-host disease?. Bone Marrow Transplant, 39:7, pp. 435-437.
25. Elhasid, R., Arush, MB Zaidman, I. et al. (2007) Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T-cell depletion and no posttransplantation graft-versus-host-disease prophylaxis. Biol Blood Marrow Transplant, 13:3, pp. 329-338.
26. Vanikar, AV, Modi, PR Patel, RD et al. (2007) Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc, 39:3, pp. 703-708.
27. Flynn, CM and Kaufman, DS (2007) Donor cell leukemia: Insight into cancer stem cells and the stem cell niche. Blood, 109:7, pp. 2688-2692.
28. Marmont, AM, Gualandi, F. Occhini, D. et al. (2006) Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity, 39:6, pp. 505-511.
29. Marmont, AM (2006) Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: Great expectations but controversial evidence. Bone Marrow Transplant, 38:1, pp. 1-4.
30. Tyndall, A. (2006) Allogeneic bone marrow transplantation for autoimmune disease-the jury is still out. J Rheumatol, 33:4, pp. 644-646.
31. Burt, RK, Loh, Y. Pearce, W. et al. (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA, 299:8, pp. 925-936.
32. Illei, GG (2006) Hematopoietic stem cell transplantation in autoimmune diseases: Is the glass half full or half empty?. Arthritis Rheum, 54:12, pp. 3730-3734.
33. Gualandi, F., Bruno, B. Van Lint, MT et al. (2007) Autologous stem cell transplantation for severe autoimmune diseases: A 10-year experience. Ann N Y Acad Sci, 1110, pp. 455-464.
34. Mancardi, GL, Murialdo, A. Rossi, P. et al. (2005) Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler, 11:3, pp. 367-371.
35. Portaccio, E., Amato, MP Siracusa, G. et al. (2007) Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: Report of two cases. Mult Scler, 13:5, pp. 676-678.
36. Nash, RA, McSweeney, PA Crofford, LJ et al. (2007) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: Long-term follow-up of the US multicenter pilot study. Blood, 110:4, pp. 1388-1396.
37. Elhasid, R., Rowe, JM Berkowitz, D. et al. (2004) Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant, 33:12, pp. 1257-1259.
38. Miniati, I., Guiducci, S. Conforti, ML et al. (2008) Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis
39. Marmont, AM and Burt, AD (2008) Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases. Autoimmunity, 41:8
40. Muraro, PA and Douek, DC (2006) Renewing the T-cell repertoire to arrest autoimmune aggression. Trends Immunol, 27:2, pp. 61-67.
41. Abrahamsson, S. and Muraro, P. (2008) Immune re-education following autologous hematopoietic stem cell transplantation for autoimmune diseases. Autoimmunity, 41:8
42. Van Wijk, F., Roord, S. and Vastert, B. (2008) Regulator T cells in autologous stem cell transplantation for autoimmune disease. Autoimmunity, 41:8
43. Dingli, D. and Michor, F. (2006) Successful therapy must eradicate cancer stem cells. Stem Cells, 24:12, pp. 2603-2610.
44. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther, 69:3, pp. 89-95.
45. Brodsky, R. and Jones, R. (2008) Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages. Autoimmunity, 41:8
46. Guilhot, F. (2007) No more transplantation in CML?. Blood, 109:11, p. 4592.
47. Hehlmann, R., Berger, U. Pfirrmann, M. et al. (2007) Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood, 109:11, pp. 4686-4692.
48. Svegliati, S., Olivieri, A. Campelli, N. et al. (2007) Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood, 110:1, pp. 237-241.
49. Dazzi, F., van Laar, JM, Cope, A. and Tyndall, A. (2007) Cell therapy for autoimmune diseases. Arthritis Res Ther, 9:2, p. 206.
50. Pedersen-Bjergaard, J. (2007) Therapy-related myelodysplasia. Leukemia Res, 31, pp. 51-53.
51. Bhatia, S., Francisco, L. Carter, A. et al. (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the bone marrow transplant survivor study. Blood, 110:10, pp. 3784-3792.
52. Armitage, JO (2000) Myelodysplasia and acute leukemia after autologous bone marrow transplantation. J Clin Oncol, 18:5, pp. 945-946.
53. Cibere, J., Sibley, J. and Haga, M. (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus, 10:6, pp. 394-400.
54. Ramsey-Goldman, R. and Clarke, AE (2001) Double trouble: Are lupus and malignancy associated?. Lupus, 10:6, pp. 388-391.
55. Goding, J. (2006) Advocatus diaboli: What is not known about autoimmune disease. The autoimmune diseases, Elsevier, Amsterdam/Tokyo
56. Chiovato, L., Latrofa, F. Braverman, LE et al. (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med, 139:5, pp. 346-351.
57. Maugendre, D., Sonnet, E. Derrien, C. et al. (1999) Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease. Diabetes Metab, 25:1, pp. 28-33.
58. Bosi, E., Braghi, S. Maffi, P. et al. (2001) Autoantibody response to islet transplantation in type 1 diabetes. Diabetes, 50:11, pp. 2464-2471.
59. Sherer, Y., Gorstein, A., Fritzler, MJ and Shoenfeld, Y. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum, 34:2, pp. 501-537.
60. Tarner, IH and Fathman, CG (2006) Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?. Nat Clin Pract Rheumatol, 2:9, pp. 491-499.
61. Miller, SD, Turley, DM and Podojil, JR (2007) Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol, 7:9, pp. 665-677.
62. Siatskas, C., Chan, J. Field, J. et al. (2006) Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr Gene Ther, 6:1, pp. 45-58.
63. Alderuccio, F., Chan, J. and Toh, B-H (2008) Tweaking the immune system Gene therapy-assisted autologous haemopoietic stem cell transplantation as a treatment for autoimmune disease. Autoimmunity, 41:8
64. Marmont, AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun, 30:3, pp. 145-150.